Published in J Sports Sci Med on March 01, 2011
The anti-inflammatory effect of exercise. J Appl Physiol (1985) (2005) 6.87
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta (2006) 2.97
Exercise as cardiovascular therapy. Circulation (1999) 2.29
Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol (2004) 1.82
Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol (1996) 1.66
Therapeutic potential of vitamin D-binding protein. Trends Biotechnol (2004) 1.55
Changes in serum cartilage oligomeric matrix protein (COMP), plasma CPK and plasma hs-CRP in relation to running distance in a marathon (42.195 km) and an ultra-marathon (200 km) race. Eur J Appl Physiol (2009) 1.27
Exercise-induced oxidative stress:myths, realities and physiological relevance. Sports Med (2005) 1.22
Alpha1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol (2002) 1.18
Exercise, inflammation, and innate immunity. Immunol Allergy Clin North Am (2009) 1.18
Biochemical impact of a soccer match - analysis of oxidative stress and muscle damage markers throughout recovery. Clin Biochem (2008) 1.17
Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. J Appl Physiol (1985) (2000) 1.15
Training and testing physical capacities for elite soccer players. J Sports Sci (2005) 1.14
Gc-globulin: roles in response to injury. Clin Chem (2006) 1.12
Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans (2002) 1.08
Individual responses to aerobic exercise: the role of the autonomic nervous system. Neurosci Biobehav Rev (2008) 1.04
Acute moderate-intensity exercise in middle-aged men has neither an anti- nor proinflammatory effect. J Appl Physiol (1985) (2008) 1.03
Changes in the rat heart proteome induced by exercise training: Increased abundance of heat shock protein hsp20. Proteomics (2006) 1.02
Sport practice and osteoarthritis of the limbs. Osteoarthritis Cartilage (1997) 1.01
Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function. J Biol Chem (2004) 0.92
Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res (2007) 0.91
Effect of a short maximal physical exercise on coagulation, fibrinolysis, and complement system. Int J Sports Med (1991) 0.89
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization? Atherosclerosis (2005) 0.88
Exercise prescription and thrombogenesis. J Biomed Sci (2006) 0.84
Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk. Diabetes Obes Metab (2004) 0.84
Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost (2009) 0.83
The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine (2008) 0.83
Biochemical aspects of overtraining in endurance sports : the metabolism alteration process syndrome. Sports Med (2003) 0.82
Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl (2008) 0.82
Proteomic study of plasma from moderate hypercholesterolemic patients. J Proteome Res (2006) 0.81
A proteomic analysis of the acute effects of high-intensity exercise on skeletal muscle proteins in fasted rats. Clin Exp Pharmacol Physiol (2006) 0.81
Heart rate variability in elite American track-and-field athletes. J Strength Cond Res (2007) 0.80
Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa. Br J Sports Med (2006) 0.79
Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study. Alzheimer Dis Assoc Disord (2001) 0.78
The evaluation of cardiac complaints in marathon runners. J Emerg Med (2008) 0.76
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation. J Cardiovasc Pharmacol (2008) 0.76
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol (2005) 3.17
Left ventricular trabeculae: quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance. J Cardiovasc Med (Hagerstown) (2009) 2.84
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol (2007) 2.73
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
Circadian variations of infarct size in acute myocardial infarction. Heart (2011) 2.60
Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts. Circulation (2009) 2.23
Morphological and thermodynamic comparison of the lesions created by 4 open-irrigated catheters in 2 experimental models. J Cardiovasc Electrophysiol (2014) 2.05
Myocardial bridging assessed by multidetector computed tomography: likely cause of chest pain in younger patients with low prevalence of dyslipidemia. Rev Esp Cardiol (Engl Ed) (2012) 1.98
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol (2007) 1.94
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol (2006) 1.94
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes (2005) 1.88
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler Thromb Vasc Biol (2006) 1.84
Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol (2004) 1.82
Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy. JACC Cardiovasc Interv (2012) 1.81
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J (2004) 1.77
Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol (2004) 1.75
Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart (2012) 1.73
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention (2013) 1.72
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol (2006) 1.72
Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res (2006) 1.71
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med (2010) 1.70
Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol (2012) 1.68
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention (2011) 1.58
Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J (2006) 1.57
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv (2009) 1.56
Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation (2013) 1.55
Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention. J Invasive Cardiol (2006) 1.54
Non-invasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real-time 3D echocardiography. Eur Heart J (2004) 1.54
Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol (2004) 1.53
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II. EuroIntervention (2009) 1.48
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. Lancet (2002) 1.47
Errors in pulmonary vein identification and ostia location in the absence of pulmonary vein imaging. Heart Rhythm (2005) 1.46
Direct measurement of proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography in mitral regurgitation: a validation study. J Am Soc Echocardiogr (2012) 1.46
LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study. Eur Heart J (2005) 1.45
Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome? Int J Cardiol (2007) 1.43
Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol (2009) 1.43
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study. J Invasive Cardiol (2004) 1.43
Prognostic influence of mitral regurgitation prior to a first myocardial infarction. Eur Heart J (2004) 1.42
[Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome]. Rev Esp Cardiol (2008) 1.42
KATP channel opening accelerates and stabilizes rotors in a swine heart model of ventricular fibrillation. Cardiovasc Res (2013) 1.41
Three-dimensional echocardiographic assessment of left atrial size and function and the normal range of asynchrony in healthy individuals. Rev Esp Cardiol (2009) 1.41
Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study ("Control de HIperglucemia y Actividad Plaquetaria en Pacientes con Síndrome Coronario Agudo"). J Thromb Thrombolysis (2013) 1.40
Negative predictive value of dipyridamole vs. dobutamine stress echocardiography in the long-term follow-up of patients undergoing major vascular surgery. Rev Port Cardiol (2004) 1.39
[Differentiating between atrial flutter and atrial fibrillation using right atrial bipolar endocardial signals]. Rev Esp Cardiol (2007) 1.39
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation (2005) 1.38
Meta-analysis comparing the effect of drug-eluting versus bare metal stents on risk of acute myocardial infarction during follow-up. Am J Cardiol (2007) 1.38
Skeletal myoblast implants induce minor propagation delays, but do not promote arrhythmias in the normal swine heart. Europace (2010) 1.38
Identifying patients without favourable long-term outcome among those with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram. Eur J Echocardiogr (2004) 1.38
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study]. Rev Esp Cardiol (2011) 1.37
Morphometric assessment of coronary stenosis relevance with optical coherence tomography: a comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol (2012) 1.29
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes (2006) 1.27
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol (2010) 1.21
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res (2005) 1.17
Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol (2003) 1.16
Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J (2010) 1.11
Combined use of OCT and IVUS in spontaneous coronary artery dissection. JACC Cardiovasc Imaging (2013) 1.09
Comparison of left ventricular volumes and ejection fractions measured by three-dimensional echocardiography versus by two-dimensional echocardiography and cardiac magnetic resonance in patients with various cardiomyopathies. Am J Cardiol (2005) 1.09
Transient inferior dyskinesia: The Tako-Tsubo syndrome applied to the right coronary artery. Int J Cardiol (2006) 1.07
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease. Thromb Res (2005) 1.07
Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study. J Am Coll Cardiol (2004) 1.06
Acute mitral stenosis after transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.06
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol (2010) 1.05
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol (2008) 1.05
Three-dimensional-wall motion tracking: a new and faster tool for myocardial strain assessment: comparison with two-dimensional-wall motion tracking. J Am Soc Echocardiogr (2009) 1.05
Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome. EuroIntervention (2006) 1.05
Real-time three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach. J Am Coll Cardiol (2004) 1.04
Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.02
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention (2005) 1.00
Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J Am Coll Cardiol (2010) 0.99
Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction. EuroIntervention (2013) 0.99
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention (2008) 0.98
Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. Am J Cardiol (2009) 0.98
Disagreement between tissue Doppler imaging and conventional pulsed wave Doppler in the measurement of myocardial performance index. Eur J Echocardiogr (2005) 0.98
Albendazole for the treatment of anisakiasis ileus. Clin Infect Dis (2005) 0.97
Association of blood pressure and its evolving changes with the survival of patients with heart failure. J Card Fail (2008) 0.97
Early myocardial deformation changes associated to isolated obesity: a study based on 3D-wall motion tracking analysis. Obesity (Silver Spring) (2011) 0.96
Primary stenting in acute myocardial infarction secondary to right coronary artery dissection following blunt chest trauma. Usefulness of intracoronary ultrasound. Int J Cardiol (2005) 0.96
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Am J Cardiol (2005) 0.95
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol (2006) 0.95
Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J (2007) 0.94
Tako-tsubo syndrome and heart failure: long-term follow-up. Rev Esp Cardiol (Engl Ed) (2012) 0.93
Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. EuroIntervention (2006) 0.93
Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol (2007) 0.93
Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure. J Cardiovasc Electrophysiol (2008) 0.93
A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol (2003) 0.93
Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. Eur J Heart Fail (2007) 0.92
Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1). Cardiovasc Res (2008) 0.91
Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res (2007) 0.91
Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol (2011) 0.90
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol (2006) 0.90
Very late mycotic pseudoaneurysm associated with drug-eluting stent fracture. Circulation (2012) 0.90
Diaphragm paralysis due to pseudoaneurysm of internal mammary artery after pacemaker implantation. Europace (2010) 0.90
Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr (2011) 0.90
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv (2011) 0.89